U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
118501118501A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care SettingCompletedNo Results AvailableChronic Obstructive Pulmonary Diseasehttps://ClinicalTrials.gov/show/NCT01013922
118502118502Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs PlaceboCompletedNo Results AvailableTinea PedisDrug: Bifonazole spray once daily|Drug: Bifonazole spray twice daily|Drug: Placebo|Drug: Placebo|Drug: Lamisil Oncehttps://ClinicalTrials.gov/show/NCT01013909
118503118503Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) ExperienceCompletedNo Results AvailableCystic FibrosisBehavioral: Motivational Interviewing|Other: Cystic Fibrosis Educationhttps://ClinicalTrials.gov/show/NCT01013896
118504118504The Darlington Retrospective Outpatient StudyCompletedHas ResultsHeart Failurehttps://ClinicalTrials.gov/show/NCT01013883
118505118505Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical ProtocolActive, not recruitingNo Results AvailableMild Traumatic Brain Injury|Post-traumatic Stress DisorderDrug: Atorvastatin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01013870
118506118506Treating to Target for Patients With HypertensionCompletedNo Results AvailableHypertensionBehavioral: Health coaching|Behavioral: Health coaching plus home titrationhttps://ClinicalTrials.gov/show/NCT01013857
118507118507Partner Assistance in Learning and Performing Skin Self-ExaminationCompletedHas ResultsMelanomaBehavioral: Skin Self Examination Information and ABCDE Rulehttps://ClinicalTrials.gov/show/NCT01013844
118508118508Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the LungTerminatedNo Results AvailableDysplasia|Metaplasia|Pulmonary Precancerous ConditionDrug: Erlotinib Hydrochloride|Other: Laboratory Biomarker Analysis|Other: Pharmacological Studyhttps://ClinicalTrials.gov/show/NCT01013831
118509118509A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid MalignanciesTerminatedNo Results AvailableLymphoid MalignanciesDrug: HGS1029https://ClinicalTrials.gov/show/NCT01013818
118510118510Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal CancerCompletedNo Results AvailableRectal CancerRadiation: External Beam Radiotherapy|Drug: Oxaliplatin|Drug: Fluorouracil|Drug: Leucovorin|Procedure: Surgical Resectionhttps://ClinicalTrials.gov/show/NCT01013805
118511118511A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot UlcersTerminatedHas ResultsFoot Ulcer, DiabeticDevice: Wound Dressing|Device: Wound Dressinghttps://ClinicalTrials.gov/show/NCT01013792
118512118512Merkel Positron Emission Tomography (PET) ProtocolRecruitingNo Results AvailableMerkel Cell CarcinomaDrug: Carboplatin|Drug: Etoposide|Radiation: Radiotherapyhttps://ClinicalTrials.gov/show/NCT01013779
118513118513A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 DiabeticsCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: GSK1362885|Drug: GSK1362885https://ClinicalTrials.gov/show/NCT01013766
118514118514A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.CompletedHas ResultsAsthmaDrug: Placebo|Drug: Olodaterol (BI 1744) high|Drug: Olodaterol (BI 1744) medium|Drug: Olodaterol (BI 1744) very low|Drug: Formoterol 12 mcg|Drug: Olodaterol (BI 1744) lowhttps://ClinicalTrials.gov/show/NCT01013753
118515118515Lapatinib in Combination With VinorelbineActive, not recruitingHas ResultsCancerDrug: Vinorelbine|Drug: Lapatinib|Drug: Capecitabinehttps://ClinicalTrials.gov/show/NCT01013740
118516118516Functional Neuroimaging of Postural ReconstructionCompletedNo Results AvailableHealthyRadiation: SPECT : ECD-Tc99m - Neurolite, Bristol-Myers Squibb Medical Imaginghttps://ClinicalTrials.gov/show/NCT01013727
118517118517Cardiac Denervation Surgery for Prevention of Ventricular TacharrhythmiasNot yet recruitingNo Results AvailableSudden Cardiac Death|Ventricular Tachycardia|Ventricular Fibrillation|CardiomyopathyProcedure: Bilateral cervicothoracic sympathectomy plux maximum medical therapy|Drug: Maximum medical therapyhttps://ClinicalTrials.gov/show/NCT01013714
118518118518Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid DiseaseNot yet recruitingNo Results AvailablePatients With Nasal PolypsDrug: fluticasone furoate|Other: placebohttps://ClinicalTrials.gov/show/NCT01013701
118519118519Efficiency of Radiofrequency Ablation for Surgical Treatment of Chronic Atrial Fibrillation With Rheumatic Valve DiseaseRecruitingNo Results AvailableRheumatic Valve Disease|Atrial FibrillationProcedure: Cardioblate® Surgical Ablation Systemhttps://ClinicalTrials.gov/show/NCT01013688
118520118520Immunogenicity and Safety of a Cell-derived Influenza Vaccine in ElderlyCompletedNo Results AvailableInfluenza VaccinesBiological: Influenza Vaccine|Biological: Influenza Vaccinehttps://ClinicalTrials.gov/show/NCT01013675
118521118521Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic ControlCompletedNo Results AvailableSeptic Shock|SepsisProcedure: glycemic controlhttps://ClinicalTrials.gov/show/NCT01013662
118522118522Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By SurgeryRecruitingNo Results AvailablePancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Pancreatic Intraductal Papillary-Mucinous Neoplasm|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic CancerRadiation: 3-Dimensional Conformal Radiation Therapy|Drug: Capecitabine|Drug: Erlotinib Hydrochloride|Drug: Fluorouracil|Drug: Gemcitabine Hydrochloride|Radiation: Intensity-Modulated Radiation Therapy|Other: Laboratory Biomarker Analysis|Other: Quality-of-Life Assessmenthttps://ClinicalTrials.gov/show/NCT01013649
118523118523Human Anaplasmosis in Eastern FranceRecruitingNo Results AvailableAnaplasmosis|Tick-borne Disease|EhrlichiaProcedure: Blood samplinghttps://ClinicalTrials.gov/show/NCT01013636
118524118524Stage IV Surgery Versus Best Medical TherapyTerminatedNo Results AvailableStage IV Resectable MelanomaProcedure: Surgery|Procedure: Surgery plus 2 adjuvant doses of BCG|Other: best medical therapyhttps://ClinicalTrials.gov/show/NCT01013623
118525118525An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's DiseaseCompletedNo Results AvailableMild Alzheimer's DiseaseDrug: LNK-754|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01013610
118526118526Trial of LBH589 in Metastatic Thyroid CancerActive, not recruitingNo Results AvailableThyroid CarcinomaDrug: LBH589https://ClinicalTrials.gov/show/NCT01013597
118527118527The Effect of Weight on Vitamin D Dose ResponseCompletedNo Results AvailableObesity|Vitamin D DeficiencyDietary Supplement: cholecalciferolhttps://ClinicalTrials.gov/show/NCT01013584
118528118528Self Titration With Apidra to Reach Target Study (START)CompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: insulin glargine|Drug: Apidra (insulin glulisine)https://ClinicalTrials.gov/show/NCT01013571
118529118529New Options for Preoperative Anesthesia in Intrauterine NeedlingCompletedNo Results AvailableStress|PainDrug: Remifentanil|Drug: salinehttps://ClinicalTrials.gov/show/NCT01013558
118530118530Developmental and Augmented Intervention for Facilitating Expressive LanguageCompletedNo Results AvailableJoint Engagement + Enhanced Milieu Training|Joint Engagement + Enhanced Milieu Training+Augmentative Communication (AAC)Behavioral: JAE Interventionhttps://ClinicalTrials.gov/show/NCT01013545

* Görseller ve İçerik tekif hakkına sahip olabilir